Nagaraja Srivatsan

Chief Executive Officer, Endpoint Clinical

Professional Overview

Nagaraja Srivatsan is a seasoned technology executive with over two decades of experience driving digital transformation and growth across the healthcare and life sciences industries. As the Chief Executive Officer of Endpoint Clinical, he leverages his deep domain expertise and strategic vision to guide the company's mission to provide innovative clinical trial solutions that enhance patient experiences and accelerate drug development.

Experience Summary

Current Role

As the Chief Executive Officer of Endpoint Clinical, Nagaraja is responsible for setting the strategic direction of the company and leading its global operations. Under his leadership, Endpoint Clinical has established itself as a trusted partner to top pharmaceutical and biotechnology firms, helping them navigate the complex clinical trial landscape through the deployment of cutting-edge technology and data-driven insights.

Career Progression

Prior to his current role, Nagaraja held various executive positions, including Chief Digital Officer at IQVIA, where he spearheaded the development and implementation of transformative digital solutions for the R&D and Technology Solutions division. He also served as the Executive Vice President and Chief Growth Officer at EXL, where he was instrumental in driving the company's expansion into new markets and service lines. Additionally, Nagaraja has held senior leadership roles at Cognizant Technology Solutions, where he led the company's Emerging Business Accelerator and played a pivotal role in shaping its healthcare technology strategy.

Academic Background

Nagaraja holds a Bachelor's degree in Computer Science from the University of Madras, India.

Areas of Expertise

Nagaraja's areas of expertise span digital transformation, healthcare technology, data analytics, and strategic business development. He is a recognized thought leader in the clinical trial space, known for his ability to navigate complex regulatory environments and drive innovation in patient-centric trial design and execution.

Professional Impact

Under Nagaraja's leadership, Endpoint Clinical has achieved significant milestones, including the successful implementation of its proprietary cloud-based platform, which has enabled clients to streamline their clinical trial operations and improve patient engagement. Additionally, Nagaraja has been actively involved in industry initiatives, serving on the advisory boards of several leading healthcare organizations and contributing to the development of industry standards and best practices.

Conclusion

With his extensive experience, strategic vision, and commitment to innovation, Nagaraja Srivatsan is well-positioned to guide Endpoint Clinical's continued growth and solidify its position as a leading provider of cutting-edge clinical trial solutions in the healthcare and life sciences sectors.